Abstract
Background
Following spinal cord injury (SCI), the routine use of magnetic resonance imaging (MRI) resulted in an incremental diagnosis of posttraumatic syringomyelia (PTS). However, facing four decades of preferred surgical treatment of PTS, no clear consensus on the recommended treatment exists. We review the literature on PTS regarding therapeutic strategies, outcomes, and complications.
Methods
We performed a systematic bibliographic search on (“spinal cord injuries” [Mesh] AND “syringomyelia” [Mesh]). English language literature published between 1980 and 2020 was gathered, and case reports and articles examining syrinx due to other causes were excluded. The type of study, interval injury to symptoms, severity and level of injury, therapeutic procedure, duration of follow-up, complications, and outcome were recorded.
Results
Forty-three observational studies including 1803 individuals met the eligibility criteria. The time interval from SCI to the diagnosis of PTS varied between 42 and 264 months. Eighty-nine percent of patients were treated surgically (n = 1605) with a complication rate of 26%. Symptoms improved in 43% of patients postoperatively and in 2% treated conservatively. Stable disease was documented in 50% of patients postoperatively and in 88% treated conservatively. The percentage of deterioration was similar (surgery 16%, 0.8% dead; conservative 10%). Detailed analysis of surgical outcome with regard to symptoms revealed that pain, motor, and sensory function could be improved in 43 to 55% of patients while motor function deteriorated in around 25%. The preferred methods of surgery were arachnoid lysis (48%) and syrinx drainage (31%).
Conclusion
Even diagnosing PTS early in its evolution with MRI, to date, no satisfactory standard treatment exists, and the present literature review shows similar outcomes, regardless of the treatment modality. Therefore, PTS remains a neurosurgical challenge. Additional research is required using appropriate study designs for improving treatment options.
Keywords: Syringomyelia, Trauma, Hydromyelia, Treatment, Etiology, Spinal cord injury
Introduction
Over the past decades, due to the more frequent routine use of magnetic resonance imaging (MRI) in the diagnostic process and follow-up for back pain and spine injuries, even distinctive features are increasingly detected. The attribution of a T2-hyperintense medullary signal as a prominent central canal, hydro- and syringomyelia has been classified by Milhorat [40, 41]. However, diagnostic criteria and terminology are used inconsistently. Batnitzky [6] differentiated primary congenital and secondary acquired forms of syringomyelia due to trauma, infection, tumor, or vascular disturbances. The pathophysiological mechanism of congenital syringomyelia is explained by the absence of a perforation of the rhombic roof and formation of the foramen Magendie during fetal weeks 6 to 8 [21], resulting in a persistent patent central canal. Conversely, acquired syringomyelia has been linked to intermittent sharp increases in cerebrospinal fluid (CSF) pressure associated with venous pressure fluctuations as the underlying distending force [61]. An experimental modeling of a phase difference between the pressure pulse in the spinal subarachnoid space and the perivascular spaces suggests that mechanical perturbations caused by arachnoiditis exacerbate the phase-lag effect [15]. As soon as the intrinsic fluid storage capacity of the spinal cord is overloaded, medullary edema may develop, presenting as a hyperintense T2-weighted signal and referred to as the “pre-syrinx” state [20].
Following spinal cord injury (SCI), local ischemia, liquefaction of hematoma, and/or autolytic processes, as well as subarachnoid scars limit the CSF flow [17], thereby rendering the development of possible posttraumatic syringomyelia (PTS). In PTS, delayed progressive myelopathy develops often corresponding to spinal segments distant from the level of the original lesion. Besides CSF flow disturbances, posttraumatic kyphosis and the resulting spinal canal stenosis may promote the progression of PTS [1, 44].
Concerning preferred therapeutic strategies, in 2010, a consensus panel gave a strong recommendation for surgical intervention in the setting of motor neurological deterioration and a weak recommendation for spinal cord untethering with expansive duraplasty as the preferred first-line surgical technique [7]. Furthermore, they recommended no decompression at the time of initial injury to limit the future risk of syringomyelia, or for patients developing pain, sensory loss or for asymptomatic but expanding syrinx [7]. While for cervical spondylotic myelopathy, two randomized controlled trials (RCT) compare different surgical techniques [19, 22], no RCT, or, at least, a prospective observational study compares a non-operative to surgical treatment—neither in cervical myelopathy nor in PTS. Here, we present the results of a systematic literature search on PTS for treatment strategy, outcome, and complications.
Methods
Eligibility
All studies describing the treatment or reporting the effects of treatment of PTS from 1980 to 2020 were included in this review. Case reports including less than three individuals and animal studies were not included. Apart from this, no restrictions were placed on the study type (experimental or observational studies), or sample size.
Literature search and data extraction
The retrieval of studies was performed in PubMed using the combined filter and Medical Subject Headings (MeSH) term: (“spinal cord injuries” [Mesh] AND “syringomyelia” [Mesh]). Additionally, the Cochrane Central Register of Controlled Trials (CENTRAL), the Cochrane Database of Systematic Reviews, Web of Science, Scopus, and Google Scholar were searched for eligible studies. All records were screened based on title and abstract independently by two authors (FDS and AK) separately. In cases of discordance, the records were included in the full-text screening. Finally, the remaining records were evaluated by reading the full-text papers. All relevant characteristics (study type, sample size, level and severity of the injury, interval injury to symptoms, surgical technique, follow-up period, main findings) reported in the manuscripts were extracted into evidence tables. Due to a high level of heterogeneity of the studies and many insufficient study designs, no pooled effect estimates were calculated. Instead, a descriptive summary was carried out.
Risk of bias assessment
Since the Newcastle-Ottawa Scale (NOS) is only suitable for assessing the quality of case-control and prospective cohort studies, we used a risk-of-bias measurement instrument based on the NOS but also suitable for studies which cannot be subsumed under these gold standard observational study designs. A detailed description of this tool has been published by Dodoo-Schittko et al. [12]. All included studies were evaluated by two authors (AK and FDS). Subsequently, disparate ratings were discussed until consensus was reached.
Results
Systematic literature search
The electronic search revealed 599 scientific reports, and the PRISMA flow diagram of the screening process is presented in Fig. 1. After screening the title and abstract, 61 articles were included in the full-text screening process. One study was excluded because of overlapping data [54], and one because the full text was not available in English [10]. Finally, a total of 43 studies met the eligibility criteria. The extracted information of these studies is shown in Table 1. All cohorts/samples were independent, and we could not identify any overlap of included individuals. Overall, the sample sizes of the clinical studies detected by literature search ranged from case series of three up to studies including 600 individuals [2, 4, 5, 9, 11, 13, 14, 16, 18, 23–40, 42–53, 55, 56, 59, 60, 62]. Observational designs were applied in all studies. One study used an experimental design investigating the effect of shunt insertion on syrinx length and size in an animal model [8] and an observational study in dogs [3]. Both were excluded because they were not including human subjects.
Table 1.
Author [ref]; study type; sample size | Interval injury symptoms | Severity of spinal cord injury | Level of syrinx | Surgical technique | Follow-up | Findings | Complications of surgery | Conclusions of authors |
---|---|---|---|---|---|---|---|---|
Shannon [50]; observational; N = 13 | 107 months | 54% incomplete; 46% complete | 13% cervical; 56% thoracic; 31% lumbar | 100% surgery—77% syringostomy and 23% cord transection | 18 months | 77% complete relief of severe pain was main symptom | n.a. | Syringostomy relieves pain, has a low morbidity, but does not alter sensory symptoms |
Vernon [58]; observational; N = 27 | 101 months | 46% incomplete; 54% complete | 14% cervical; 69% thoracic; 17% lumbar | 100% surgery—22% syringostomy, 37% syringo-subarachnoid drain, 22% syringo-peritoneal drain, and 19% cord transsection | 60 months | 44% improved; 15% stable; 41% deteriorated | 29% complication—19% shunt dysfunction, 7% CSF leak, and 4% wound complication | Remissions occur up to 1–5 years; surgery improves symptoms not always, 2 patients deteriorated postop |
Rossier [45]; oberservational; N = 30 | 108 months | 60% complete; 40% incomplete | 100% cervical | 63% conservative (N = 19); 37% syringo-subarachnoid drain (N = 11) | n.a. | Conservative—32% stable and 68% deteriorated; surgery—73% improved | 45% complication—18% early neurological deterioration and 27% late neurological deterioration | Some symptoms in conservatively treated patients remained stable over a number of years |
Suzuki [51]; observational; N = 17 | 72 months | n.a. | n.a. | 100% syringo-peritoneal drain | 12 months | 82% improved; 18% stable | 17% shunt dysfunction | Surgery simple and effective if disease not too advanced |
Anton [4]; observational; N = 9 | 68 months | 22% incomplete; 78% complete | 34% cervical; 54% thoracic; 12% lumbar | 33% conservative (N = 3); 67% syringo-peritoneal drain (N = 6) | n.a. | Conservative—100% stable; surgery—68% improved, 16% stable, and 16% dead | 16% shunt dysfunction | Ability to perform activities of daily living not changed by surgery |
Williams [61]; observational; N = 8 | 99 months | 38% incomplete; 62% complete | 25% cervical; 63% thoracic; 12% lumbar | 100% arachnoid lysis+syringo-pleural drain | n.a. | 38% improved; 38% stable; 25% deteriorated | 25% shunt dysfunction | Syrinx drain may improve symptoms |
Vaquero [57]; observational; N = 9 | 74 months | 100% incomplete | n.a. | 100% syringo-subarachnoid drain | 19 months | 45% improved; 55% stable | 11% neurological deterioration | Syringo-subarachnoid drain recommended |
Lyons [37]; observational; N = 14 | 101 months | 43% incomplete; 57% complete | 6% medulla oblongata; 59% cervical; 5% thoracic; 15% atrophic cord; 15% no syrinx but abnormal cord | 20% conservative (N = 3); 80% surgery (N = 11)—8% syringostomy, 8% syringo-subarachnoid drain, 8% syringo-peritoneal drain, 50% syringo-cisternal drain, and 18% cord transsection | 24 months | Conservative—33% improved, 67% stable; surgery—68% improved, 16% stable, and 16% deteriorated | 83% complication—30% shunt dysfunction, 25% wound complication, 8% meningitis, 8% subdural hematoma, and 8% neurological deterioration | Surgery recommended in progressive SM with neurological deterioration; abnormal cord considered precursor of syrinx |
La Haye [33]; observational; N = 8 | 96 months | 100% incomplete | 66% cervical; 34% thoracic | 13% conservative (N = 1); 87% surgery (N = 7)—86% cysto-peritoneal drain without valve | 40 months | Conservative—100% stable; surgery—86% improved and 14% deteriorated | n.a. | Cyst drainage by pressure difference |
Tator [52]; observational; N = 11 | 83 months | n.a. | n.a. | 100% surgery—9% syringostomy, 73% syringo-subarachnoid drain, 9% arachnoid lysis+syringo-subarachnoid drain, and 9% cord transsection | 55 months | 55% improved; 18% stable; 27% deteriorated | 27% shunt dysfunction | Duration of symptoms and neurological deficit correlated to outcome; early surgery warranted in progressive, symptomatic SM |
Padovani [42]; observational; N = 4 | 72 months | 100% incomplete | n.a. | 100% syringo-subarachnoid drain | 60 months | 50% improved; 50% stable 100% MRI improved | 25% neurological deficit | No relationship between duration of symptoms and outcome |
Hida [24]; observational; N = 14 | 148 months | 36% incomplete; 64% complete | 35% cervical; 35% thoracic; 30% lumbar | 22% conservative (N = 3); 78% surgery (N = 11)—54% syringo, subarachnoid drain, 36% syringo-peritoneal drain, and 10% ventriculo-peritoneal shunt | 44 months | Conservative, 100% stable; surgery, 100% improved and 100% MRI improved | 80% shunt dysfunction | Syringo-subarachnoid drain should be first option |
Edgar [12]; observational; N = 525 | 240 months | 18% incomplete 82% complete | 75% cervical; 24% thoracic; 1% lumbar | 100% surgery—syringostomy, syrinx drain, and cord transsection | 26 months | 87% improved if symptoms < 3 months; 44% improved if symptoms > 6 months 231/525 | 26% complication—12% shunt dysfunction, 5% neurological deficit (transient), 4% CSF leak, 3% neurological deficit (permanent), 1% wound complication, and 0.4% spine instability | Myelopathy can precede SM; untethering and duraplasty very successful with preference for early intervention |
Wiart [59]; observational; N = 8 | 54 months | 62% incomplete; 38% complete | 62% cervical; 25% thoracic | 100% syringo-peritoneal drain | 54 months | 50% improved; 50% deteriorated; 100% MRI improved | 50% neurological deterioration | Syringo-peritoneal drain is efficient in syrinx treatment but does not prevent meningeal fibrosis |
Sgouros [49]; observational; N = 57 | 91 months | 28% incomplete; 72% complete | 23% cervical; 67% thoracic; 10% lumbar | 100% surgery—14% arachnoid lysis, 4% syringostomy, 11% syringo-subarachnoid drain, 49% syringo-pleural drain, and 28% cord transection ± drain | 90 months | 83% stable; 53% of drains effective after 4 years | 42% complication—29% drain related (dyslocation, occlusion, broncho-pleural fistula, infection), 4% wound complication, 3% meningitis, 3% pneumo-cephalus, and 1% CSF leak | Decompressive laminectomy together with reconstruction of subarachnoid space more effective and fewer complications |
el Masry [13]; observational; N = 26 | 101 months | 32% incomplete; 68% complete | 32% cervical; 46% thoracic; 22% lumbar | 14% conservative (N = 4); 86% surgery (N = 22)—5% syringostomy, 30% syringo-subarachnoid drain, 55% syringo-pleural drain 12, and 10% cord transsection | 36 months | Conservative—100% stable; surgery—60% improved, 28% stable, and 14% deteriorated | 16% complication—8% air embolims, 4% pneumocephalus, and 4% wound complication | No difference of results with regard to level/extend of syrinx or severity of initial injury; no shunt procedure superior |
Schurch [48]; pbservational; N = 20 | 112 months | 20% incomplete; 80% complete | 60% cervical; 40% thoracic | 65% conservative (N = 13); 35% surgery (N = 7)—29% spinal stabilization, 29% syringostomy, and 42% syringo-subarachnoid drain | 70 months | Conservative—77% stable and 23% deteriorated; surgery—72% improved, 14% stable, and 14% deteriorated | n.a. | Close relationship between medullar compression, kyphosis, and neurological deterioration; re-alignment and stabilization can prevent PTS |
Asano 1996 [5]; observational; N = 9 | 80 months | n.a. | 34% cervical; 66% thoracic | 44% conservative (N = 4); 56% syringo-subarachnoid drain (N = 5) | n.a. | Conservative—100% stable; surgery—100% improved | 40% shunt dysfunction | Pre-op MRI may help to identify “high-pressure” syrinx |
Kramer [32]; observational; N = 17 | n.a. | 33% incomplete; 67% complete | 33% cervical; 66% thoracic | 53% conservative (N = 9); 47% syringostomy (N = 8) | 43 months | Conservative—23% improved, 33% stable, and 44% deteriorated; surgery—75% improved and 25% deteriorated | No complication | Pain and sensory deficit respond better to surgery than spasticity |
Ronen [44]; observational; N = 10 | 104 months | 50% incomplete; 50% complete | 50% cervical; 10% thoracic; 40% lumbar | 50% conservative (N = 5) only rehabilitation; 50% surgery+rehabilitation (N = 5)—20% laminectomy and 80% syringo-subarachnoid drain | Conservative—70 months; surgery—66 months | Conservative—20% improved, and 80% stable; Surgery—20% stable and 80% deteriorated | No complication | No clear evidence for the superiority of surgery |
Schaller [47]; observational; N = 12 | 146 months | 17% incomplete; 83% complete | 17% cervical; 75% thoracic; 8% lumbar | 100% surgery—17% arachnoid lysis and 83% arachnoid lysis+syringo-peritoneal drain (low pressure) | 44 months | n.a. | 30% shunt failure | Better results without drain |
Hess [23]; observational; N = 8 | 120 months | 50% incomplete; 50% complete | 63% cervical; 25% thoracic; 22% lumbar | 100% surgery—87% syringo-subarachnoid drain and 13% syringo-pleural drain | 180 months | 87% improved; 13% deteriorated | 50% shunt failure; 25% new syrinx | Less pain and improved strength are more significant than decreased numbness |
Holly [25]; observational; N = 5 | 24–264 months | 20% incomplete; 80% complete | 20% cervical; 20% thoracic; 10% lumbar | 100% surgery; ventral epidural decompression | 38 months | 80% improved; 20% stable | n.a. | Anatomical reconstruction of spinal deformities recommended |
Lee [38]; observational; N = 34 | 132 months | n.a. | 65% cervical; 25% thoracic; 10% lumbar | 100% surgery—(A) 41% arachnoid lysis if tethering, (B) 47% syringo-subarachnoid drain if no tethering, and (C) 12% arachnoid lysis+drain if tethering and persistent cyst | 29 months | 76% improved; 18% stable; 6% deteriorated; 90% MRI improved | 32% complication—(A) 7% failure, 14% complication, (B) 13% failure, 13% complication, and (C) 25% CSF leak, 75% neurological deficit (transient) | Arachnoid lysis is effective if tethering and intra-op cyst collapse |
Lee 2001 [39]; observational; N = 45 | 78 months | n.a. | 62% cervical; 30% thoracic; 8% lumbar | 100% surgery—40% arachnoid lysis, 38% syringo-subarachnoid drain, 20% arachnoid lysis+drain, and 2% arachnoid lysis, subsequent drain | 23 months | 33% improved, 15—60% stable, 27; 7% deteriorated, 3; 93% MRI improved, 42 | 16% complication—7% shunt failure, 2% CSF leak, and 7% neurological deficit (transient) | Untethering can reduce cyst size and alleviate symptoms in the majority; duraplasty may be more physiological |
Schaan [46]; observational; N = 30 | 42 months | 20% incomplete; 80% complete | 33% cervical; 67% thoracic | 100% surgery—(A) drain; (B) arachnoid lysis+drain+duraplasty—73% syringo-subarachnoid drain, 13% syringo-peritoneal drain, and 3% syringo-pleural drain; and (C) arachnoid lysis+duraplasty | (A) 80 months; (B) 52 months; and (C) 46 months | 50% improved; 33% stable; 14% deteriorated; 3% dead | 1 death caused by pneumonia (3%) | No significant difference for pain, motor deficit, sensory deficit between surgical procedures |
Lee [36]; observational; N = 3 | n.a. | 100% incomplete | 66% thoracic; 33% holocord | 100% surgery—33% arachnoid lysis+duraplasty and 67% arachnoid lysis+syringo-subarachnoid drain | 14 months | 66% improved; 33% stable | No complication | Restoration of CSF flow by decompression more effective than syrinx drain |
Carroll [11]; observational; N = 15 | 70 months | 50% incomplete; 50% complete | 31% cervical; 56% thoracic; 7% lumbar | 6% conservative (N = 1); 94% surgery (N = 14)—47% syringo, peritoneal drain, 32% syringostomy+syringo-peritoneal drain, 7% arachnoid lysis, and 7% duraplasty | n.a. | Conservative—100% stable; surgery—31% improved, 25% stable, 19% deteriorated, 13% unavailable, and 6% dead | 6% dead 1 | Surgery has a positive effect on symptom progression, although no recommendation on optimal intervention |
Jaksche [28]; observational; N = 58 | n.a. | n.a. | n.a. | 100% surgery—17% drain and 83% arachnoid lysis+duraplasty | 120 | 59% improved; 29% stable; 9% deteriorated;3% dead | 80% shunt dysfunction; 3% dead (pulmonary embolism) | Restoration of normal CSF flow reduces shearing force on spinal cord |
Laxton [35]; observational; N = 4 | 123 months | 50% incomplete; 50% complete | 25% cervical; 75% thoracic | 100% cord transsection | 54 months | 100% improved | No complication | Cord transsection should be avoided in incomplete SCI |
Lam [34]; observational; N = 3 | n.a. | 100% incomplete | 67% cervical; 33% thoracic | 100% subarachnoid-peritoneal drain—level C4 for C0-Th1 and level Th4 below Th1 | 33 months | 100% improved | 67% complication—33% shunt dysfunction and 33% cerebellar tonsillar descent | Risk of cerebellar tonsillar descent |
Cacciola [9]; observational; N = 8 | n.a. | n.a. | 13% cervical; 63% thoracic; 13% lumbar; 13% holocord | 100% syringo-pleural drain | 38 months | 50% improved; 24% stable; 13% deteriorated; 13% dead | 20% postmyelotomy pain; 13% dead | Causal surgery should be performed first; shunt placement is second-line option |
Falci [17]; observational; N = 362 | 128 months | 63% ASIA (A); 10% ASIA (B); 11% ASIA (C) 14% ASIA (D); 1% ASIA (E) | 68% cervical; 32% thoracic | 100% surgery—80% arachnoid lysis+duraplasty and 20% syringo-subarachnoid/peritoneal drain | 144 months | 59% improved spasticity—90% stable and 0.5% dead | 7% complication—4% CSF leak, 1% deep venous thrombosis, 1% pulmonary embolism, 0.5% meningitis, 0.5% wound complication, 0.5% dead, and 0.2% myocardial infarction | No significant change ASIA pre- and postop; surgery recommended in progressive myelopathy |
Ushewokunze [54]; observational; N = 40 | 72 months | 40% incomplete; 60% complete | n.a. | 100% duraplasty—43% additional procedures (29% revision of duraplasty, 76% lumbo/ventriculo-peritoneal shunt, 6% syringostomy, 35% syringo-subarachnoid/pleural/peritoneal drain, 6% percutaneous syrinx aspiration) | 64 months | 68% stable; 32% deteriorated; 23% MRI improved at 6 months | 43% complication—13% dysaesthic pain, 10% neurological deficit, 10% wound complication, 5% CSF leak, 3% posterior fossa subdural haematoma, and 3% hydrocephalus | Decompression and arachnoid lysis have limited effect on the long-term symptoms |
Ewelt [15]; observational; N = 15 | n.a. | 53% incomplete; 47% complete | 6 levels (range 1–16) | 100% arachnoid lysis+cord transsection | 24 months | 40% improved; 53% stable; 7% deteriorated | No complication | Cord transsection alternative option for progressive SM and adhesive arachnoitis |
Oluigbo [41]; observational; N = 5 | n.a. | 100% incomplete | 40% cervical; 60% thoracic | 100% surgery—80% decompression+lumbo-peritoneal shunt and 20% lumbo-peritoneal shunt | 25 months | 40% improved; 60% deteriorated; 60% MRI improved | 60% shunt revision | Lumbo-peritoneal drain indicated if no CSF obstruction visible |
Aghakhani [2]; observational; N = 34 | 133 months | 100% incomplete | 9% cervical; 70% thoracic; 21% lumbar | 100% surgery—(A) 56% arachnoid lysis and (B) 44% drain | (A) 84 months; (B) 46 months | (A) 73% improved, 21% stable, and 5% deteriorated; (B) 47% stable and 53% deteriorated | 68% complication—53% shunt revision, 9% CSF leak, 3% meningitis, and 3% pneumonia | Early correction of spinal canal stenosis essential; subarachnoid space reconstruction and cyst opening is safe and effective |
Klekamp [31]; observational; N = 137 | 135 months | 33% ASIA (A + B); 0% ASIA (C + D); 27% ASIA (E) | 22% cervical; 66% thoracic; 12% lumbar | 55% conservative (N = 76); 45% surgery (N = 61)—88% arachnoid lysis+duraplasty and 3% cord transection | Conservative—67 months; surgery n.a. | Conservative—67% stable; Surgery: ASIA (A + B)—65% improved and 35% stable; ASIA (C + D)—52% improved, 39% stable, and 9% deteriorated; ASIA E—38% improved, 50% stable, 13% deteriorated | 16% complication, 13% revision, 8% neurological deficit (transient), 5% wound infection, 5% hematoma, 2% CSF leak, 2% cardiac arrest, 22% 5-year recurrence, and 56% 10-year recurrence | Decompression with arachnolysis, untethering, and duraplasty provides good long-term results for patients with progressive neurological symptoms; Treatment of patients with preserved motor functions remains a major challenge |
Isik [27]; N = 19 | 24 months | n.a. | n.a. | 100% surgery—11% syringostomy, 26% syringo-subarachnoid drain, and 63% syringo-pleural drain | 108 months | 82% improved; 6% stable; 12% deteriorated; 100% MRI improved | 47% complication—20% neurological deficit (transient), 2% drain dislocation, 12% revision, and 6% neurological deficit (permanent) | Syringo-pleural shunt produced satisfactory results at long-term follow-up |
Hayashi [22]; observational; N = 20 | 126 months | 45% incomplete; 55% complete | 20% cervical; 55% thoracic; 25% lumbar | 100% arachnoid lysis+syringo-subarachnoid drain | 48 months | 60% improved; 20% stable; 20% deteriorated | No complication | No correlation pre- and postop ASIA; correlation clinical outcome and syrinx size |
Kim [30]; observational; N = 9 | 264 months | 100% incomplete | 67% cervical; 33% thoracic | 100% surgery—33% syringo-subarachnoid drain, 44% arachnoid lysis+duraplasty, and 22% syringo-pleural drain | 112 months | 11% improved; 44% stable; 44% deteriorated | 33% complication—22% shunt dysfunction and 11% wound complication | Unfavorable long-term outcome with surgery |
Karam [29]; observational; N = 27 | 144 months | 52% ASIA (A); 11% ASIA (C); 37% ASIA (D) | 15% cervical; 78% thoracic; 7% lumbar | 100% surgery—60% drain (12% syringo-pleural, 88% syringo-subarachnoid), 25% arachnoid lysis+syringo-pleural drain+duraplasty, and 15% arachnoid lysis+duraplasty | 216 months | 52% improved; 37% stable; 11% deteriorated | 62% revision of drain; 27% revision of duraplasty | Duraplasty and arachnoid lysis preferred over drain |
Holmstrom [26]; observational; N = 17 | n.a. | n.a. | 53% cervical; 41% thoracic; 6% lumbar | 100% arachnoid lysis+syringo-subarachnoid drain | n.a. | 50% improved; 31% stable; 19% deteriorated (3/16); 66% MRI improved (6/9) | n.a. | Untethering and cyst drainage resulted in patient satisfaction |
n.a., not available; CSF, cerebrospinal fluid; SM, syringomyelia; PTS, posttraumatic syringomyelia; MRI, magnetic resonance imaging; SCI, spinal cord injury; ASIA, American Spinal Injury Association
Patients characteristics
The studies collect data from 1803 patients. The time interval from the spinal injury to the onset of symptoms varies between 42 and 264 months. Pain, motor, and sensory function compromise are the most frequent symptoms, while autonomic dysfunction is uncommon. Complete SCI preponderates (mean 63%) over incomplete (mean 37%). The most frequent locations of spinal injuries were the thoracic region (mean 48%) and the cervical region (mean 41%). The lumbar region (mean 10%) and medulla oblongata (mean < 1%) were hardly affected.
Clinical outcome
The mean follow-up period was 56 months in the observational studies. While 89% of patients were treated surgically, of the remaining 11% treated conservatively, only those of Ronen et al. [45] received a rehabilitation (n = 5). The summarized results of the surgical and conservative treatment are presented in Table 2. Following surgery for PTS, 43% of patients improved clinically, and the MRI findings in 75% of patients; 50% remained stable, 16% deteriorated, and 0.8% died peri-procedural. Sufficient information about complications of the performed surgical procedures is not available in all studies. Six studies do not describe complications, and in another six studies, no complications were observed. Out of the 403 complications following surgery (26%), a drain or valve dysfunction was most often reported (21%). A CSF leak was reported in 2.9%, a transient neurological deficit in 2.8%, a permanent neurological deficit in 2.5%, and wound complications were reported in 2% of patients. Other complications included venous thromboembolic event (N = 7), meningitis (N = 6), pneumocephalus (N = 3), air embolism (N = 2), cerebellar tonsillar descent (N = 1), and cardiac arrest (N = 1).
Table 2.
Detailed results of treatment | Surgery (N = 1605) | Conservative (N = 198) |
---|---|---|
MRI improved | 123/164 (75%) | n.a. |
Improved | 510/1175 (43%) | 4 (2%) |
Stable | 585/1078 (50%) | 174 (88%) |
Deteriorated | 108/659 (16%) | 20 (10%) |
Dead | 8/1021 (0.8%) | n.a. |
Complications | 403/1561 (26%) | n.a. |
Drain or valve dysfunction | 207/973 (21%) | |
CSF leak | 46/1561 (2.9%) | |
Transient neurological deficit | 44/1561 (2.8%) | |
Permanent neurological deficit | 39/1561 (2.5%) | |
Wound complication | 32/1561 (2.0%) | |
Other | ||
Venous thromboembolic events | 7 | |
Meningitis | 6 | |
Pneumencephalus | 3 | |
Subdural hematoma | 2 | |
Air embolism | 2 | |
Cerebellar tonsillar descent | 1 | |
Cardiac arrest | 1 |
It is important to note that the comparison of surgical and conservative treatment lacks a baseline, which carries the risk of selection bias per chosen treatment
MRI, magnetic resonance imaging; CSF, cerebrospinal fluid
A detailed analysis of surgical results concerning pain, sensory, motor, and autonomic function was performed by Vernon et al. in 27 patients [59], Lee et al. in 87 patients [37, 38], and Schaan et al. in 30 patients [47]. The results are presented in Table 3. Pain is improved in 43% of patients, sensory function in 49%, and motor function in 55%. On the other hand, pain is deteriorated in 15%, sensory function in 27%, motor function in 25%, and autonomic function in almost all cases.
Table 3.
Results of treatment | Pain | Sensory function | Motor function | Autonomic dysfunction |
---|---|---|---|---|
Improved total | 46/106 (43%) | 42/85 (49%) | 50/91 (55%) | 2/15 (13%) |
Vernon [54] (total N = 27) | ||||
Syringostomy (N = 3) | 3/3 | 0/2 | 1/3 | 0/1 |
Syringostomy + drain (N = 16) | 8/14 | 7/13 | 9/13 | – |
Cord incision/transection (N = 8) | 4/6 | 3/6 | 4/4 | 0/2 |
Lee [35] (total N = 34) | ||||
Arachnoid lysis (N = 14) | 4/12 | 3/6 | 4/7 | 1/3 |
Syringo-subarachnoid drain (N = 16) | 5/13 | 3/6 | 5/10 | 0/2 |
Arachnoid lysis + drain (N = 4) | 1/4 | 1/3 | 2/3 | – |
Lee [34] (total N = 53) | ||||
Arachnoid lysis (N = 19) | 6/15 | 4/9 | 6/10 | 1/4 |
Syringo-subarachnoid drain (N = 17) | 5/13 | 4/7 | 6/11 | 0/2 |
Arachnoid lysis + drain (N = 9) | 2/8 | 2/6 | 3/6 | 0/1 |
Schaan [42] (total N = 30) | ||||
Drain procedures (N = 18) | 5/14 | 5/15 | 5/13 | – |
Drain + duraplasty (N = 5) | 1/1 | 4/5 | 3/5 | – |
Duraplasty (N = 7) | 3/3 | 6/7 | 2/6 | – |
Stable total | 11/41 (27%) | 10/48 (21%) | 9/44 (20%) | 0/3 (0%) |
Vernon 1983 [54] (total N = 27) | ||||
Syringostomy (N = 3) | 0/3 | 0/2 | 1/3 | 0/1 |
Syringostomie + drain (N = 16) | 4/14 | 1/13 | 0/13 | – |
Cord incision/transection (N = 8) | 2/6 | 0/6 | 0/4 | 0/2 |
Schaan [42] (total N = 30) | ||||
Drain procedures (N = 18) | 5/14 | 8/15 | 4/13 | – |
Drain + duraplasty (N = 5) | 0/1 | 0/5 | 1/5 | – |
Duraplasty (N = 7) | 0/3 | 1/7 | 3/6 | – |
Deteriorated total | 6/41 (15%) | 13/48 (27%) | 11/44 (25%) | 3/3 (100%) |
Vernon [54] (total N = 27) | ||||
Syringostomy (N = 3) | 0/3 | 2/2 | 1/3 | 1/1 |
Syringostomie + drain (N = 16) | 2/14 | 5/13 | 4/13 | – |
Cord incision/transection (N = 8) | 0/6 | 3/6 | 0/4 | 2/2 |
Schaan [42] (total N = 30) | ||||
Drain procedures (N = 18) | 4/14 | 2/15 | 4/13 | – |
Drain + duraplasty (N = 5) | 0/1 | 1/5 | 1/5 | – |
Duraplasty (N = 7) | 0/3 | 0/7 | 1/6 | – |
The type of surgical procedure on PTS was specified in 866 patients and is presented in Table 4. Arachnoid lysis was the procedure that was performed most often (N = 418; 48%), followed by various techniques of drain placement (N = 267; 31%). Procedures that were performed less frequently were cord transection (N = 51; 5.9%), syringostomy (N = 49; 5.7%), duraplasty (N = 41; 4.7%), a combination of arachnoid lysis and drain (N = 30; 3.5%), decompression alone (N = 5; 0.6%), or shunt alone (N = 5; 0.6%).
Table 4.
Methods of surgical treatment (N = 866) | Improved | Stable | Deter. | Complications |
---|---|---|---|---|
Arachnoid lysis (N = 418 (48%)) | ||||
Lee [35] (N = 14) | Pain 33% (4/12) | Failure 7% (1/14) | ||
Sensory 50% (3/6) | Neurol. deficit 14% (2/14) | |||
Motor 57% (4/7) | CSF leak 7% (1/14) | |||
Lee [34] (N = 19) | Pain 40% (6/15) | Failure 5% (1/19) | ||
Sensory 44% (4/9) | Neurol. deficit 11% (2/19) | |||
Motor 60% (6/10) | CSF leak 5% (4/19) | |||
Aghakhani [2] (N = 19) | Postop 16% (3/19) | 79% (15/19) | 5% (1/19) | |
Drain (syringo-subarachnoid/pleural/peritoneal) (N = 267 (31%)) | ||||
Lee [35] (N = 16) | Pain 38% (5/13) | Failure 13% (2/16) | ||
Sensory 50% (3/6) | Trans. neurol. deficit 13% (2/16) | |||
Motor 50% (5/10) | ||||
Lee [34] (N = 17) | Pain 38% (5/13) | Failure 18% (3/17) | ||
Sensory 57% (4/7) | Trans. neurol. deficit 5% (1/17) | |||
Motor 54% (6/11) | ||||
Schaan [42] (N = 18) | Pain 36% (5/14) | 36% (5/14) | 29% (4/14) | |
Sensory 33% (5/15) | 53% (8/15) | 13% (2/15) | ||
Motor 38% (5/13) | 31% (4/13) | 31% (4/13) | ||
Aghakhani [2] (N = 15) | Postop 0% (0/15) | 47% (7/15) | 53% (8/15) | |
Cord transection (N = 51 (5.9%)) | ||||
Vernon [54] (N = 5) | Pain 75% (3/4) | 25% (1/4) | 0% (0/4) | |
Sensory 40% (2/5) | 0% (0/5) | 60% (3/5) | ||
Motor 100% (3/3) | 0% (0/3) | 0% (0/3) | ||
Syringostomy (N = 49 (5.7%)) | ||||
Vernon [54] (N = 22) | Pain 63% (12/19) | 26% (5/19) | 11% (2/19) | |
Sensory 31% (5/16) | 6% (1/16) | 69% (11/16) | ||
Motor 59% (10/17) | 0% (0/17) | 41% (7/17) | ||
Duraplasty (N = 41 (4.7%)) | ||||
Schaan [42] (N = 12) | Pain 100% (4/4) | 0% (0/4) | 0% (0/4) | |
Sensory 83% (10/12) | 8% (1/12) | 8% (1/12) | ||
Motor 45% (5/11) | 36% (4/11) | 18% (2/11) | ||
Arachnoid lysis + syringo-subarachnoid drain (N = 30 (3.5%)) | ||||
Lee [35] (N = 4) | Pain 25% (1/4) | |||
Sensory 67% (2/3) | Trans. neurol. deficit 75% (3/4) | |||
Motor 67% (2/3) | CSF leak 25% (1/4) | |||
Lee [34] (N = 9) | Pain 25% (2/8) | Failure 33% (3/9) | ||
Sensory 33% (2/6) | Trans. neurol. deficit 67% (6/9) | |||
Motor 50% (3/6) | CSF leak 11% (1/9) |
Decompression (N = 5 (0.58%)). Ventriculo/lumbo-peritoneal shunt (N = 5 (0.58%))
Deter., deterioration; Neurol., neurological; CSF, cerebrospinal fluid; Trans., transient
Four studies directly compared the results of different treatment regimes in separate cohorts. The allocation process was either based on clinical findings [37, 38] or not described [2, 47], and the time point of outcome assessment is not always specified. In two separate studies, Lee et al. performed arachnoid lysis (N = 33), drain placement (N = 33), and a combination of both (N = 13). While the failure of drain placement (N = 5; 15%) is higher than of arachnoid lysis (N = 2; 6%), the incidence of procedure-related neurological deficits (9%: arachnoid lysis N = 3; drain N = 3) and the overall improvement is comparable (pain 30%: each N = 11; sensory 21%: each N = 7; motor 30–33% arachnoid lysis N = 10, drain N = 11). The results reported by Aghakhani et al. postoperatively were worse for drain placement (N = 15; improvement 0%; deterioration 53%) than for arachnolysis (N = 19: improvement 16%; deterioration 5%) but improved over time [2]. A combination of both techniques was performed in a minority of patients and was associated with a considerable morbidity (53–75%) [2, 37, 38]. Schaan et al. compared drain placement (N = 18: improvement 33–38%; deterioration 13–31%) and duraplasty (N = 12; improvement 45–100%; deterioration 0–18%) [47].
The results of the less-often performed procedures are better, although based on small sample sizes: cord incision or transection resulted in an improvement of 50 to 100% (N = 8) [58], syringostomy resulted in an improvement of 47% to 71% (N = 19) [58], and duraplasty resulted in an improvement of 33% to 100% (N = 12) [47].
Without a surgical treatment—i.e., following a “conservative” treatment—2% of patients improved and 88% remained stable, while 10% of patients deteriorated (total N = 198; Table 2) [4, 5, 11, 14, 25, 32–34, 40, 45, 46, 49].
One experimental study including six patients (male, 30–50 years) into a phase 2 trial injecting autologous mesenchymal stromal cells into the syrinx of PTS patients was not included in the above-mentioned analysis because it is a novel therapeutic approach [57]. The time interval between SCI and treatment varied from 5.8 to 27.7 years, and irrespective of syrinx size, 300 × 106 autologous expanded mesenchymal stromal cells, supported in autologous plasma were administered into the syrinx. The patients were followed up for 6 months, and the authors report in all patients variable improvement in clinical scales, mainly in the scales related to sphincter dysfunction and neuropathic pain [57].
Discussion
Over the past four decades, PTS is diagnosed more frequently and surgical techniques became more elaborate. Consequently, in a review paper (2010), Bonfield et al. presented recommendations of a consensus panel for surgical intervention in the setting of motor neurological deterioration and for spinal cord untethering with duraplasty as the preferred surgical technique [7]. Interestingly, they recommended against the direct decompression at the time of initial injury as well as against surgical interventions for patients developing pain, sensory loss, or for asymptomatic but radiologically expanding syrinx [7]. By 2020, still, no prospective study is available comparing non-operative and surgical treatment—neither in cervical myelopathy nor in PTS.
Here, we present the results of a systematic bibliographic literature search on PTS for treatment strategy, outcome, and complications. The risk of bias assessment revealed a high or unclear risk of selection bias in all studies. In addition, the risk of information bias was present in many studies, notably in the assessment of patient-reported outcome measurements. This is because of the use of non-validated measurement instruments. The present literature review reveals that 89% of the included 1803 patients were treated surgically. This fact can be probably attributed to a publication bias. Nevertheless, 12 studies including 198 PTS patients treated conservatively have been published [4, 5, 11, 14, 25, 32–34, 40, 45, 46, 49]. In contrast with the expert recommendations of 2010 [7], we also appreciate the results of these conservatively treated PTS patients.
Effect of intervention on specific symptoms
The 2010 recommendations for surgical intervention in PTS advocate spinal cord untethering with duraplasty in the setting of motor neurological deterioration but against surgery for pain and sensory deterioration [7]. When we analyzed the outcome of surgery for PTS concerning specific neurological functions (Table 3), motor and sensory dysfunction responded better than pain to an intervention (improved motor 55%, sensory 49%, pain 43%) but were also at a higher risk for deterioration (motor 25%, sensory 27%, pain 15%) while the autonomic function was at a high risk for deterioration [37, 38, 47, 59]. Hence, although it is common practice in neurosurgery to prioritize motor symptoms in decision making for surgery and in guidelines, the recommendation by Bonfield et al. do not necessarily reflect the common practice in the existing literature on PTS.
The decision as to if, when, and what type of treatment to offer to a patient with PTS has changed over the past four decades. During the 1980s and early 1990s, surgical intervention including syringostomy and syrinx drainage was the preferred treatment option [58, 60]. Drainage complications resulted in the preference for the reconstruction of the subarachnoid space [50] or even a conservative treatment [5, 14, 33, 45, 49]. Furthermore, one has to keep in mind that both, improvement as well as an arrest of deterioration, may constitute the goal of treatment.
Effect of type of surgical procedure on the outcome
The type of surgical procedure was specified in almost 900 patients (Table 4). Forty-eight percent of authors performed untethering, another 31% various techniques of drain placement, and 4% combined both procedures. Cord transection, syringostomy, or duraplasty were performed by around 5%, and less than 1% applied decompression or shunt alone. While no surgical technique for PTS provides substantially superior results, any type of drain placement is associated with a failure rate of up to 20% [37, 38, 47]. The reason for the weak recommendation of the 2010 consensus panel for spinal cord untethering with expansive duraplasty as the preferred first-line surgical technique is not obvious [7]. From a pathophysiological point of view, an individualized therapeutic approach would be desirable based on the patient’s history, symptoms, and radiological findings. After the detection of local alterations in CSF flow, the restoration of physiological flow patterns should be the first goal followed by draining CSF trapped in cysts. Duraplasty may aid in the creation of extra CSF space and avoid new scar formation. Cell transplantation therapies in PTS are under investigation, although their relevance has not been confirmed yet [57, 63].
Time interval to surgical intervention
Experimental evidence indicates that mechanical perturbations of arachnoiditis form the basis of syrinx development [15], and medullary edema in MRI can be interpreted as a “pre-syrinx “[20] as suggested by Lyons et al. in the pre-MRI area [40]. These pathophysiological considerations may stress the relevance of an early intervention to divert CSF if the spinal canal stenosis is not absolute [13, 29, 40, 53]. Irrespectively, it is self-evident that the spinal stabilization and re-alignment of fractures preventing medullar compression and kyphosis is mandatory [2, 44, 49]. Interestingly, the 2010 consensus committee recommended against the direct decompression at the time of initial injury as well as against surgical interventions for patients developing sensory loss, a pain syndrome, or for asymptomatic but expanding syrinx [7].
Some authors do not support the use of a surgical intervention in PTS, even in patients with progressive neurological deterioration [45]. Our analysis suggests that a conservative treatment as reported by some authors [4, 5, 11, 14, 25, 33, 34, 40, 45, 49] may be an alternative to surgical procedures flawed by complications. However, because of the observational design of all studies, we cannot exclude that our analysis is biased by a crossover of patients who were initially treated conservatively and were referred to a subsequent surgical treatment because of clinical deterioration. Furthermore, it is important to keep in mind that scar formation itself without PTS may result in neurological deterioration.
Conclusion
Here, we present the analysis of a systematic literature search on therapeutic options for PTS over four decades. The outcome of conservative and surgical treatment is not directly comparable because of the exclusively observational study design with the subsequent selection bias and cross-over. While a satisfying outcome defined as either an improved or stable situation is identical (conservative 85%; surgery 88%), the reduction of deterioration from 15.5% without surgery to 9.1% with surgery is accompanied by a 0.33% surgery-related mortality and 23% complications. The evidence of the efficacy of the different treatment modalities is very low mainly resulting from the application of observational study designs with a consistently high risk of selection bias. This points to the necessity of additional research using appropriate study designs to reveal the causal relationship between treatment and outcome. However, concerning the existing literature, there is no satisfactory standard treatment for syringomyelia even diagnosing PTS early in its evolution. Hence, PTS remains a neurosurgical challenge even diagnosed early in its course.
Abbreviations
- PTS
Posttraumatic syringomyelia
- SCI
Spinal cord injury
- MRI
Magnetic resonance imaging
- CT
Computed tomography
- CSF
Cerebrospinal fluid
- ASIA
American Spinal Injury Association
Funding Information
Open Access funding provided by Projekt DEAL.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
For this type of study, formal consent is not required.
Footnotes
This article is part of the Topical Collection on Spine - Other
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Andrea Kleindienst, Email: andrea.kleindienst@uk-erlangen.de.
Francisco Marin Laut, Email: miguel.laut@uca.es.
Verena Roeckelein, v.n.roeckelein@googlemail.com.
Michael Buchfelder, Email: michael.buchfelder@uk-erlangen.de.
Frank Dodoo-Schittko, Email: frank.dodoo-schittko@med.ovgu.de.
References
- 1.Abel R, Gerner HJ, Smit C, Meiners T. Residual deformity of the spinal canal in patients with traumatic paraplegia and secondary changes of the spinal cord. Spinal Cord. 1999;37:14–19. doi: 10.1038/sj.sc.3100740. [DOI] [PubMed] [Google Scholar]
- 2.Aghakhani N, Baussart B, David P, Lacroix C, Benoudiba F, Tadie M, Parker F. Surgical treatment of posttraumatic syringomyelia. Neurosurgery. 2010;66:1120–1127. doi: 10.1227/01.NEU.0000369609.30695.AB. [DOI] [PubMed] [Google Scholar]
- 3.Alisauskaite N, Spitzbarth I, Baumgartner W, Dziallas P, Kramer S, Dening R, Stein VM, Tipold A. Chronic post-traumatic intramedullary lesions in dogs, a translational model. PLoS One. 2017;12:e0187746. doi: 10.1371/journal.pone.0187746. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Anton HA, Schweigel JF. Posttraumatic syringomyelia: the British Columbia experience. Spine (Phila Pa 1976) 1986;11:865–868. doi: 10.1097/00007632-198611000-00003. [DOI] [PubMed] [Google Scholar]
- 5.Asano M, Fujiwara K, Yonenobu K, Hiroshima K. Post-traumatic syringomyelia. Spine (Phila Pa 1976) 1996;21:1446–1453. doi: 10.1097/00007632-199606150-00009. [DOI] [PubMed] [Google Scholar]
- 6.Batnitzky S, Price HI, Gaughan MJ, Hall PV, Rosenthal SJ. The radiology of syringohydromyelia. RadioGraphics. 1983;3:585–611. doi: 10.1148/radiographics.3.4.585. [DOI] [Google Scholar]
- 7.Bonfield CM, Levi AD, Arnold PM, Okonkwo DO. Surgical management of post-traumatic syringomyelia. Spine (Phila Pa 1976) 2010;35:S245–S258. doi: 10.1097/BRS.0b013e3181f32e9c. [DOI] [PubMed] [Google Scholar]
- 8.Brodbelt AR, Stoodley MA, Watling AM, Tu J, Burke S, Jones NR. Altered subarachnoid space compliance and fluid flow in an animal model of posttraumatic syringomyelia. Spine (Phila Pa 1976) 2003;28:E413–E419. doi: 10.1097/01.BRS.0000092346.83686.B9. [DOI] [PubMed] [Google Scholar]
- 9.Cacciola F, Capozza M, Perrini P, Benedetto N, Di Lorenzo N. Syringopleural shunt as a rescue procedure in patients with syringomyelia refractory to restoration of cerebrospinal fluid flow. Neurosurgery. 2009;65:471–476. doi: 10.1227/01.NEU.0000350871.47574.DE. [DOI] [PubMed] [Google Scholar]
- 10.Cao F, Yang XF, Liu WG, Li G, Zheng XS, Wen L. Surgery for posttraumatic syringomyelia: a retrospective study of seven patients. Chin J Traumatol. 2007;10:366–370. [PubMed] [Google Scholar]
- 11.Carroll AM, Brackenridge P. Post-traumatic syringomyelia: a review of the cases presenting in a regional spinal injuries unit in the north east of England over a 5-year period. Spine (Phila Pa 1976) 2005;30:1206–1210. doi: 10.1097/01.brs.0000162277.76012.0b. [DOI] [PubMed] [Google Scholar]
- 12.Dodoo-Schittko F, Brandstetter S, Blecha S, Thomann-Hackner K, Brandl M, Knuttel H, Bein T, Apfelbacher C. Determinants of quality of life and return to work following acute respiratory distress syndrome. Dtsch Arztebl Int. 2017;114:103–109. doi: 10.3238/arztebl.2017.0103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Edgar R, Quail P. Progressive post-traumatic cystic and non-cystic myelopathy. Br J Neurosurg. 1994;8:7–22. doi: 10.3109/02688699409002388. [DOI] [PubMed] [Google Scholar]
- 14.el Masry WS, Biyani A. Incidence, management, and outcome of post-traumatic syringomyelia. In memory of Mr Bernard Williams. J Neurol Neurosurg Psychiatry. 1996;60:141–146. doi: 10.1136/jnnp.60.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Elliott NS, Lockerby DA, Brodbelt AR. A lumped-parameter model of the cerebrospinal system for investigating arterial-driven flow in posttraumatic syringomyelia. Med Eng Phys. 2011;33:874–882. doi: 10.1016/j.medengphy.2010.07.009. [DOI] [PubMed] [Google Scholar]
- 16.Ewelt C, Stalder S, Steiger HJ, Hildebrandt G, Heilbronner R. Impact of cordectomy as a treatment option for posttraumatic and non-posttraumatic syringomyelia with tethered cord syndrome and myelopathy. J Neurosurg Spine. 2010;13:193–199. doi: 10.3171/2010.3.SPINE0976. [DOI] [PubMed] [Google Scholar]
- 17.Fairholm DJ, Turnbull IM. Microangiographic study of experimental spinal cord injuries. J Neurosurg. 1971;35:277–286. doi: 10.3171/jns.1971.35.3.0277. [DOI] [PubMed] [Google Scholar]
- 18.Falci SP, Indeck C, Lammertse DP. Posttraumatic spinal cord tethering and syringomyelia: surgical treatment and long-term outcome. J Neurosurg Spine. 2009;11:445–460. doi: 10.3171/2009.4.SPINE09333. [DOI] [PubMed] [Google Scholar]
- 19.Fehlings MG, Wilson JR, Kopjar B, Yoon ST, Arnold PM, Massicotte EM, Vaccaro AR, Brodke DS, Shaffrey CI, Smith JS, Woodard EJ, Banco RJ, Chapman JR, Janssen ME, Bono CM, Sasso RC, Dekutoski MB, Gokaslan ZL. Efficacy and safety of surgical decompression in patients with cervical spondylotic myelopathy: results of the AOSpine North America prospective multi-center study. J Bone Joint Surg Am. 2013;95:1651–1658. doi: 10.2106/JBJS.L.00589. [DOI] [PubMed] [Google Scholar]
- 20.Fischbein NJ, Dillon WP, Cobbs C, Weinstein PR. The “presyrinx” state: is there a reversible myelopathic condition that may precede syringomyelia? Neurosurg Focus. 2000;8:E4. doi: 10.3171/foc.2000.8.3.4. [DOI] [PubMed] [Google Scholar]
- 21.Gardner WJ. Hydrodynamic mechanism of syringomyelia: its relationship to myelocele. J Neurol Neurosurg Psychiatry. 1965;28:247–259. doi: 10.1136/jnnp.28.3.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Ghogawala Z, Martin B, Benzel EC, Dziura J, Magge SN, Abbed KM, Bisson EF, Shahid J, Coumans JV, Choudhri TF, Steinmetz MP, Krishnaney AA, King JT, Jr, Butler WE, Barker FG, 2nd, Heary RF. Comparative effectiveness of ventral vs dorsal surgery for cervical spondylotic myelopathy. Neurosurgery. 2011;68:622–630. doi: 10.1227/NEU.0b013e31820777cf. [DOI] [PubMed] [Google Scholar]
- 23.Hayashi T, Ueta T, Kubo M, Maeda T, Shiba K. Subarachnoid-subarachnoid bypass: a new surgical technique for posttraumatic syringomyelia. J Neurosurg Spine. 2013;18:382–387. doi: 10.3171/2013.1.SPINE12828. [DOI] [PubMed] [Google Scholar]
- 24.Hess MJ, Foo D. Shunting for syringomyelia in patients with spinal cord injuries: self-reported, long-term effects in 8 patients. Arch Phys Med Rehabil. 2001;82:1633–1636. doi: 10.1053/apmr.2001.25075. [DOI] [PubMed] [Google Scholar]
- 25.Hida K, Iwasaki Y, Imamura H, Abe H. Posttraumatic syringomyelia: its characteristic magnetic resonance imaging findings and surgical management. Neurosurgery. 1994;35:886–891. doi: 10.1227/00006123-199411000-00012. [DOI] [PubMed] [Google Scholar]
- 26.Holly LT, Johnson JP, Masciopinto JE, Batzdorf U. Treatment of posttraumatic syringomyelia with extradural decompressive surgery. Neurosurg Focus. 2000;8:E8. doi: 10.3171/foc.2000.8.3.8. [DOI] [PubMed] [Google Scholar]
- 27.Holmstrom U, Tsitsopoulos PP, Flygt H, Holtz A, Marklund N. Neurosurgical untethering with or without syrinx drainage results in high patient satisfaction and favorable clinical outcome in post-traumatic myelopathy patients. Spinal Cord. 2018;56:873–882. doi: 10.1038/s41393-018-0094-y. [DOI] [PubMed] [Google Scholar]
- 28.Isik N, Elmaci I, Isik N, Cerci SA, Basaran R, Gura M, Kalelioglu M. Long-term results and complications of the syringopleural shunting for treatment of syringomyelia: a clinical study. Br J Neurosurg. 2013;27:91–99. doi: 10.3109/02688697.2012.703350. [DOI] [PubMed] [Google Scholar]
- 29.Jaksche H, Schaan M, Schulz J, Bosczcyk B. Posttraumatic syringomyelia--a serious complication in tetra- and paraplegic patients. Acta Neurochir Suppl. 2005;93:165–167. doi: 10.1007/3-211-27577-0_29. [DOI] [PubMed] [Google Scholar]
- 30.Karam Y, Hitchon PW, Mhanna NE, He W, Noeller J. Post-traumatic syringomyelia: outcome predictors. Clin Neurol Neurosurg. 2014;124:44–50. doi: 10.1016/j.clineuro.2014.06.007. [DOI] [PubMed] [Google Scholar]
- 31.Kim HG, Oh HS, Kim TW, Park KH. Clinical features of post-traumatic Syringomyelia. Korean J Neurotrauma. 2014;10:66–69. doi: 10.13004/kjnt.2014.10.2.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Klekamp J. Treatment of posttraumatic syringomyelia. J Neurosurg Spine. 2012;17:199–211. doi: 10.3171/2012.5.SPINE11904. [DOI] [PubMed] [Google Scholar]
- 33.Kramer KM, Levine AM (1997) Posttraumatic syringomyelia: a review of 21 cases. Clin Orthop Relat Res:190–199 [PubMed]
- 34.La Haye PA, Batzdorf U. Posttraumatic syringomyelia. West J Med. 1988;148:657–663. [PMC free article] [PubMed] [Google Scholar]
- 35.Lam S, Batzdorf U, Bergsneider M. Thecal shunt placement for treatment of obstructive primary syringomyelia. J Neurosurg Spine. 2008;9:581–588. doi: 10.3171/SPI.2008.10.08638. [DOI] [PubMed] [Google Scholar]
- 36.Laxton AW, Perrin RG. Cordectomy for the treatment of posttraumatic syringomyelia. Report of four cases and review of the literature. J Neurosurg Spine. 2006;4:174–178. doi: 10.3171/spi.2006.4.2.174. [DOI] [PubMed] [Google Scholar]
- 37.Lee TT, Alameda GJ, Gromelski EB, Green BA. Outcome after surgical treatment of progressive posttraumatic cystic myelopathy. J Neurosurg. 2000;92:149–154. doi: 10.3171/spi.2000.92.2.0149. [DOI] [PubMed] [Google Scholar]
- 38.Lee TT, Alameda GJ, Camilo E, Green BA. Surgical treatment of post-traumatic myelopathy associated with syringomyelia. Spine (Phila Pa 1976) 2001;26:S119–S127. doi: 10.1097/00007632-200112151-00020. [DOI] [PubMed] [Google Scholar]
- 39.Lee JH, Chung CK, Kim HJ. Decompression of the spinal subarachnoid space as a solution for syringomyelia without Chiari malformation. Spinal Cord. 2002;40:501–506. doi: 10.1038/sj.sc.3101322. [DOI] [PubMed] [Google Scholar]
- 40.Lyons BM, Brown DJ, Calvert JM, Woodward JM, Wriedt CH. The diagnosis and management of post traumatic syringomyelia. Paraplegia. 1987;25:340–350. doi: 10.1038/sc.1987.62. [DOI] [PubMed] [Google Scholar]
- 41.Milhorat TH, Johnson RW, Milhorat RH, Capocelli AL, Jr, Pevsner PH. Clinicopathological correlations in syringomyelia using axial magnetic resonance imaging. Neurosurgery. 1995;37:206–213. doi: 10.1227/00006123-199508000-00003. [DOI] [PubMed] [Google Scholar]
- 42.Oluigbo CO, Thacker K, Flint G. The role of lumboperitoneal shunts in the treatment of syringomyelia. J Neurosurg Spine. 2010;13:133–138. doi: 10.3171/2010.3.SPINE0964. [DOI] [PubMed] [Google Scholar]
- 43.Padovani R, Cavallo M, Gaist G. Surgical treatment of syringomyelia: favorable results with syringosubarachnoid shunting. Surg Neurol. 1989;32:173–180. doi: 10.1016/0090-3019(89)90175-4. [DOI] [PubMed] [Google Scholar]
- 44.Perrouin-Verbe B, Robert R, Lefort M, Agakhani N, Tadie M, Mathe JF. Post-traumatic syringomyelia. Neurochirurgie. 1999;45(Suppl 1):58–66. [PubMed] [Google Scholar]
- 45.Ronen J, Catz A, Spasser R, Gepstein R. The treatment dilemma in post-traumatic syringomyelia. Disabil Rehabil. 1999;21:455–457. doi: 10.1080/096382899297440. [DOI] [PubMed] [Google Scholar]
- 46.Rossier AB, Foo D, Shillito J, Dyro FM. Posttraumatic cervical syringomyelia. Incidence, clinical presentation, electrophysiological studies, syrinx protein and results of conservative and operative treatment. Brain. 1985;108(Pt 2):439–461. doi: 10.1093/brain/108.2.439. [DOI] [PubMed] [Google Scholar]
- 47.Schaan M, Jaksche H. Comparison of different operative modalities in post-traumatic syringomyelia: preliminary report. Eur Spine J. 2001;10:135–140. doi: 10.1007/s005860000197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Schaller B, Mindermann T, Gratzl O. Treatment of syringomyelia after posttraumatic paraparesis or tetraparesis. J Spinal Disord. 1999;12:485–488. doi: 10.1097/00002517-199912000-00007. [DOI] [PubMed] [Google Scholar]
- 49.Schurch B, Wichmann W, Rossier AB. Post-traumatic syringomyelia (cystic myelopathy): a prospective study of 449 patients with spinal cord injury. J Neurol Neurosurg Psychiatry. 1996;60:61–67. doi: 10.1136/jnnp.60.1.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Sgouros S, Williams B. A critical appraisal of drainage in syringomyelia. J Neurosurg. 1995;82:1–10. doi: 10.3171/jns.1995.82.1.0001. [DOI] [PubMed] [Google Scholar]
- 51.Shannon N, Symon L, Logue V, Cull D, Kang J, Kendall B. Clinical features, investigation and treatment of post-traumatic syringomyelia. J Neurol Neurosurg Psychiatry. 1981;44:35–42. doi: 10.1136/jnnp.44.1.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Suzuki M, Davis C, Symon L, Gentili F. Syringoperitoneal shunt for treatment of cord cavitation. J Neurol Neurosurg Psychiatry. 1985;48:620–627. doi: 10.1136/jnnp.48.7.620. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Tator CH, Briceno C. Treatment of syringomyelia with a syringosubarachnoid shunt. Can J Neurol Sci. 1988;15:48–57. doi: 10.1017/S0317167100027190. [DOI] [PubMed] [Google Scholar]
- 54.Tator CH, Meguro K, Rowed DW. Favorable results with syringosubarachnoid shunts for treatment of syringomyelia. J Neurosurg. 1982;56:517–523. doi: 10.3171/jns.1982.56.4.0517. [DOI] [PubMed] [Google Scholar]
- 55.Ushewokunze SO, Gan YC, Phillips K, Thacker K, Flint G. Surgical treatment of post-traumatic syringomyelia. Spinal Cord. 2010;48:710–713. doi: 10.1038/sc.2010.17. [DOI] [PubMed] [Google Scholar]
- 56.Vaquero J, Martinez R, Salazar J, Santos H. Syringosubarachnoid shunt for treatment of syringomyelia. Acta Neurochir. 1987;84:105–109. doi: 10.1007/BF01418834. [DOI] [PubMed] [Google Scholar]
- 57.Vaquero J, Hassan R, Fernandez C, Rodriguez-Boto G, Zurita M. Cell therapy as a new approach to the treatment of posttraumatic syringomyelia. World Neurosurg. 2017;107:1047 e1045–1047 e1048. doi: 10.1016/j.wneu.2017.08.019. [DOI] [PubMed] [Google Scholar]
- 58.Vernon JD, Silver JR, Ohry A. Post-traumatic syringomyelia. Paraplegia. 1982;20:339–364. doi: 10.1038/sc.1982.64. [DOI] [PubMed] [Google Scholar]
- 59.Vernon JD, Silver JR, Symon L. Post-traumatic syringomyelia: the results of surgery. Paraplegia. 1983;21:37–46. doi: 10.1038/sc.1983.6. [DOI] [PubMed] [Google Scholar]
- 60.Wiart L, Dautheribes M, Pointillart V, Gaujard E, Petit H, Barat M. Mean term follow-up of a series of post-traumatic syringomyelia patients after syringo-peritoneal shunting. Paraplegia. 1995;33:241–245. doi: 10.1038/sc.1995.55. [DOI] [PubMed] [Google Scholar]
- 61.Williams B. Syringomyelia. Br Med J. 1970;1:434. doi: 10.1136/bmj.1.5693.434. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Williams B, Page N. Surgical treatment of syringomyelia with syringopleural shunting. Br J Neurosurg. 1987;1:63–80. doi: 10.3109/02688698709034342. [DOI] [PubMed] [Google Scholar]
- 63.Wirth ED, 3rd, Reier PJ, Fessler RG, Thompson FJ, Uthman B, Behrman A, Beard J, Vierck CJ, Anderson DK. Feasibility and safety of neural tissue transplantation in patients with syringomyelia. J Neurotrauma. 2001;18:911–929. doi: 10.1089/089771501750451839. [DOI] [PubMed] [Google Scholar]